| ANALYTICAL REPORT |
|
| Year : 2012 | Volume
: 8
| Issue : 3 | Page : 442-444 |
|
|
Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma: A case report and review of literature
Kajal Shah1, Sudeep Gupta1, Jaya Ghosh1, Jyoti Bajpai1, Amita Maheshwari2
1 Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
2 Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
Correspondence Address:
Sudeep Gupta
Department of Medical Oncology, Tata Memorial Hospital, Mumbai - 400012
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-1482.103530
|
|
|
We report a case of an acute non-ST elevation myocardial infarction (AMI) induced by paclitaxel in a patient with ovarian cancer. A 45-year-old premenopausal lady without any co-morbidity was started on the first cycle of neoadjuvant chemotherapy with paclitaxel-based regimen for advanced stage ovarian cancer. The patient developed chest pain 3 h after paclitaxel infusion with characteristic electrocardiographic changes of antero-apical myocardial infarction. The patient recovered on conservative medical management with reversion of electrocardiogram (ECG) changes. Cardiac ischemia and myocardial infarction, possibly due to coronary vasospasm, are rare adverse effects of paclitaxel with reported incidence of 0.26%. We have reported a case of paclitaxel-induced myocardial infarction with reversible cardiac dysfunction. The possibility of myocardial infarction should be considered in patients who develop chest pain or other symptoms after paclitaxel infusion. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
